Why the FDA Wants to Include Men in Breast Cancer Clinical Trials
by Ann Pietrangelo on September 12, 2019
“Since there is such a small number of men with breast cancer, including them in clinical trials could potentially take resources from women, who are 99 percent more likely to get it,” said Dr. Constance M. Chen, a board-certified plastic surgeon and breast reconstruction specialist in New York.
“That said, the number of male breast cancer patients is not zero and it is difficult to answer the question of whether male breast cancer patients need different treatment without a study,” she told Healthline.
Click HERE for the full article.